The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts
Open accessAbstract
The clinical use of anti-oestrogens in breast cancer therapy has traditionally been restricted to tumours that contain measurable oestrogen receptor protein. However, it is now widely recognised that the clinical response to adjuvant anti-oestrogen therapy appears to be independent of the oestrogen receptor content of the primary tumour. The study reported here was designed to investigate the possibility that human stromal cells can respond to anti-oestrogens by an increased synthesis of the inhibitory growth factor, transforming growth factor beta (TGF-beta). Two established human fetal fibroblast strains were used as models for the breast cancer stromal fibroblasts. These cells were found to respond to the addition of anti-oestrogens by a large increase in their synthesis of biologically active TGF-beta. Despite the application of ligand binding, immunoassay and Northern analysis, no oestrogen receptor or oestrogen receptor mRNA was detected in either of the human fetal fibroblasts strains. These observations may provide a mechanism of action of anti-oestrogens that is independent of the presence of oestrogen receptor in the tumour epithelial cells, and thus provide an explantation for the counter-intuitive results of adjuvant anti-oestrogen action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Molecular Cloning. A Laboratory Manual
Wood, E. (1983) · Biochemical Education · doi:10.1016/0307-4412(83)90068-7 · Cited by 29,533
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Knabbe, C., Lippman, M. E., Wakefield, L. M., Flanders, K. C., Kasid, A., Derynck, R., & Dickson, R. B. (1987) · Cell · doi:10.1016/0092-8674(87)90193-0 · Cited by 975
Self-citationIdentification of a new class of steroid hormone receptors
Giguère, V., Yang, N., Segui, P., & Evans, R. M. (1988) · Nature · doi:10.1038/331091a0 · Cited by 867
Distribution and modulation of the cellular receptor for transforming growth factor-beta.
Wakefield, L. M., Smith, D. M., Masui, T., Harris, C. C., & Sporn, M. B. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.2.965 · Cited by 535
Self-citationA MONOHYDROXYLATED METABOLITE OF TAMOXIFEN WITH POTENT ANTIOESTROGENIC ACTIVITY
JORDAN, V. C., COLLINS, M. M., ROWSBY, L., & PRESTWICH, G. (1977) · Journal of Endocrinology · doi:10.1677/joe.0.0750305 · Cited by 506
Danielpour, D., Dart, L. L., Flanders, K. C., Roberts, A. B., & Sporn, M. B. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041380112 · Cited by 444
Self-citationAdjuvant tamoxifen in the management of operable breast cancer : Scottish Trial
Scottish Cancer Trials Office (1987) · The Lancet · Cited by 428
Glick, A. B., Flanders, K. C., Danielpour, D., Yuspa, S. H., & Sporn, M. B. (1989) · Cell Regulation · doi:10.1091/mbc.1.1.87 · Cited by 330
Self-citationNormal embryo fibroblasts release transforming growth factors in a latent form
Lawrence, D. A., Pircher, R., Krycève‐Martinerie, C., & Jullien, P. (1984) · Journal of Cellular Physiology · doi:10.1002/jcp.1041210123 · Cited by 327
Identification of another member of the transforming growth factor type beta gene family.
ten Dijke, P., Hansen, P., Iwata, K. K., Pieler, C., & Foulkes, J. G. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4715 · Cited by 324
Wakeling, A. E., & Bowler, J. (1987) · Journal of Endocrinology · doi:10.1677/joe.0.112r007 · Cited by 321
CONTROLLED TRIAL OF TAMOXIFEN AS SINGLE ADJUVANT AGENT IN MANAGEMENT OF EARLY BREAST CANCER
(1985) · The Lancet · doi:10.1016/s0140-6736(85)92206-8 · Cited by 309
'Nolvadex', A. A. E. Y. B., & Adjuvant Trial Organisation. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.138 · Cited by 250
ADJUVANT TAMOXIFEN IN THE MANAGEMENT OF OPERABLE BREAST CANCER: THE SCOTTISH TRIAL
Breast Cancer Trials Committee (1987) · The Lancet · doi:10.1016/s0140-6736(87)90762-8 · Cited by 225
Jakowlew, S. B., Dillard, P. J., Sporn, M. B., & Roberts, A. B. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-12-1186 · Cited by 221
Self-citationSkidmore, J. C., Walpole, A. L., & Woodburn, J. R. (1972) · Journal of Endocrinology · doi:10.1677/joe.0.0520289 · Cited by 114
Pircher, R., Lawrence, D. A., & Jullien, P. (1984) · PubMed · Cited by 111
Variant Estrogen Receptor mRNA Species Detected in Human Breast Cancer Biopsy Samples
Murphy, L. C., & Dotzlaw, H. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-4-687 · Cited by 107
Kondaiah, P., Obberghen‐Schilling, E. V., Ludwig, R., Dhar, R., Sporn, M. B., & Roberts, A. B. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81361-3 · Cited by 94
Self-citationWatts, C. K. W., Murphy, L. C., & Sutherland, R. L. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43033-x · Cited by 67
Haggie, J. A., Howell, A., Sellwood, R. A., Birch, J. M., & Schor, S. L. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92206-9 · Cited by 61
Peto, R. (2008) · Hormone Research · doi:10.1159/000181336 · Cited by 40
Cited by
Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)
Roberts, A. B., & Sporn, M. B. (1993) · Growth Factors · doi:10.3109/08977199309029129 · Cited by 755
Self-citationBasic Guide to the Mechanisms of Antiestrogen Action
Macgregor, J. I., & Jordan, V. C. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01358-9 · Cited by 694
Latent transforming growth factor-β: Structural features and mechanisms of activation
Munger, J. S., Harpel, J. G., Gleizes, P.-E., Mazzieri, R., Nunes, I., & Rifkin, D. B. (1997) · Kidney International · doi:10.1038/ki.1997.188 · Cited by 511
Mechanisms of tamoxifen-induced apoptosis
Mandlekar, S., & Kong, A.-N. T. (2001) · Apoptosis · doi:10.1023/a:1012437607881 · Cited by 394
Krueger, E. A., Wilkins, E. G., Strawderman, M., Cederna, P., Goldfarb, S., Vicini, F. A., & Pierce, L. J. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01402-4 · Cited by 386
Metadata
- Authors
- Colletta, A., Wakefield, L., Howell, F., van Roozendaal, K., Danielpour, D., Ebbs, Sr., Sporn, M., & Baum, M.
- Venue
- British Journal of Cancer
- Published
- 1990-09
- Volume
- 62
- Issue
- 3
- Pages
- 405-409
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2041508666
- Cited by
- 318
- References
- 25
- FWCI
- 12.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.